Avalo Therapeutics Gross Profit (Quarterly) Analysis

Avalo Therapeutics Inc (AVTX)

14.36 -1.03 (-6.69%) USD | NASDAQ | May 03, 16:00

14.20 -0.16 (-1.11%) After-Hours: 20:00

Gross Profit (Quarterly) Chart

Historical Gross Profit (Quarterly) Data

View and export this data back to 2017. Upgrade now.

Date	Value
December 31, 2023	0.792M
September 30, 2023	-0.011M
June 30, 2023	-0.065M
March 31, 2023	-0.076M
December 31, 2022	0.276M
September 30, 2022	14.42M
June 30, 2022	-0.534M
March 31, 2022	0.453M
December 31, 2021	-0.205M
September 30, 2021	0.442M
June 30, 2021	3.272M
March 31, 2021	0.396M
December 31, 2020	1.418M

Date	Value
September 30, 2020	1.034M
June 30, 2020	1.26M
March 31, 2020	2.688M
December 31, 2019	0.5356M
September 30, 2019	2.069M
June 30, 2019	2.889M
March 31, 2019	1.824M
December 31, 2018	-4.177M
September 30, 2018	0.9635M
June 30, 2018	3.362M
March 31, 2018	3.619M
December 31, 2017	1.598M
September 30, 2017	25.04M

Gross Profit Definition

Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.

Read full definition.

Gross Profit (Quarterly) Range, Past 5 Years

-0.534M

Minimum

Jun 2022

14.42M

Maximum

Sep 2022

1.634M

Average

0.5356M

Median

Dec 2019

Gross Profit (Quarterly) Benchmarks